FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) State Street Global Advisors & Affiliates
Company dealt in Allergan plc
Class of relevant security to which
the dealings being disclosed relate (Note 2)		 US$0.0001 ordinary shares
Date of dealing 20th  September 2019
   

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

  Long Short
  Number (%) Number (%)
(1) Relevant securities 15,487,844 4.72014%    
(2) Derivatives (other than options) N/A      
(3) Options and agreements to
purchase/sell		 N/A      
Total 15,487,844 4.72014%    

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
  Number (%) Number (%)
(1) Relevant securities N/A      
(2) Derivatives (other than options) N/A      
(3) Options and agreements to purchase/sell N/A      
Total N/A      

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit (Note 5)
Purchase 122 166.46
Purchase 600 166.46
Purchase 200 166.46
Purchase 1,900 166.46
Purchase 3,500 166.46
Purchase 600 166.46
Purchase 1,100 166.46
Purchase 449 166.46
Purchase 11,400 166.46
Purchase 1,900 166.40
Purchase 300 166.46
Purchase 135 166.47
Purchase 107 166.46
Purchase 238 166.47
Purchase 60 166.46
Purchase 42 166.46
Purchase 5,900 166.46
Purchase 9,300 166.46
Purchase 23,700 166.46
Purchase 293 166.46
Purchase 3,100 166.46
Purchase 500 166.46
Purchase 94,600 166.46
Purchase 1,800 166.46
Purchase 1,100 166.46
Purchase 1,200 166.46
Purchase 178 166.46
Purchase 26 166.46
Purchase 154 166.46
Purchase 224 166.46
Purchase 23 166.46
Purchase 228,700 166.46
Purchase 5,694 166.47
Purchase 97,400 166.46
Purchase 230 166.47
Purchase 46 166.47
Purchase 6,300 166.47
Purchase 505 166.47
Purchase 283 166.47
Purchase 3,300 166.46
Purchase 800 166.46
Purchase 7,000 166.46
Purchase 500 166.46
Purchase 2,000 166.46
Purchase 32 166.46
Purchase 32 166.46
Purchase 25 166.46
Purchase 36 166.46
Purchase 5,800 166.46
Purchase 66 167.25
Purchase 200 166.46
Purchase 900 166.46
Purchase 1,000 166.46
Purchase 700 166.46
Purchase 1,000 166.46
Purchase 258 166.46
Purchase 100 166.46
Purchase 100 166.46
Purchase 800 166.46
Purchase 131 166.46
Purchase 29 166.46
Purchase 61 166.46
Purchase 200 166.46
Sale 1,100 166.53
Sale 115 166.47
Sale 200 166.47
Sale 197 166.47
Sale 20,887 166.47

 (b) Derivatives transactions (other than options transactions)

Product name,
e.g. CFD		 Nature of transaction

(Note 6)		 Number of relevant securities

(Note 7)		 Price per unit

(Note 5)
N/A      

                                                                                                                                                     
(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,
e.g. call option		 Writing, selling,
purchasing
 varying etc.		 Number of
securities to which
the option relates
(Note 7)		 Exercise
price		 Type, e.g.
American,
European etc.		 Expiry
date		 Option money
paid/received
per unit (Note 5)
N/A            

(ii) Exercising

Product name,
e.g. call option		 Number of securities Exercise price per
unit (Note 5)
N/A    

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction
(Note 8)		 Details Price per unit
(if applicable) (Note 5)
N/A    

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
N/A


Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 23rd September 2019
Contact name Chetan Shah
Telephone number                                                             020 33956564
If a connected EFM, name of offeree/offeror with which connected N/A
If a connected EFM, state nature of connection (Note 10) N/A